erythrosine has been researched along with anisomycin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benhar, M; Dalyot, I; Engelberg, D; Levitzki, A | 1 |
1 other study(ies) available for erythrosine and anisomycin
Article | Year |
---|---|
Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress.
Topics: 3T3 Cells; Animals; Anisomycin; Antineoplastic Agents; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line, Transformed; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Enzyme Activation; ErbB Receptors; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Humans; Immunoblotting; In Situ Nick-End Labeling; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 3; MAP Kinase Kinase 6; Mice; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Plasmids; Protein Synthesis Inhibitors; Protein-Tyrosine Kinases; Reactive Oxygen Species; Stress, Physiological; Time Factors; Transfection | 2001 |